Characteristics of COVID-19 vaccinated and unvaccinated patients admitted to Careggi University Hospital, Florence,

Riccardo Paggi1, Anna Barbiero1, Tommaso Manciulli1

  • 1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Insights

COVID-19 vaccinated patients, even those with breakthrough infections, showed similar outcomes to unvaccinated individuals. However, vaccinated patients lacking antibodies had higher mortality, emphasizing the need for early treatment in vulnerable groups.

Area of Science:

  • Immunology
  • Epidemiology
  • Public Health

Background:

  • Over 11.5 billion COVID-19 vaccine doses administered globally.
  • Vaccine effectiveness against severe disease is high (89.0%), but breakthrough infections occur.
  • Fragile populations remain at risk for severe outcomes despite vaccination.

Purpose of the Study:

  • To evaluate COVID-19 outcomes in vaccinated versus unvaccinated patients in a real-world setting.
  • To investigate the impact of serological status on outcomes among vaccinated individuals.
  • To identify factors influencing in-hospital mortality and resource utilization.

Main Methods:

  • Real-world observational study of 420 COVID-19 admitted patients (July 2021-January 2022).
  • Collected data on vaccination status, SARS-CoV-2 serology, treatments, oxygen support, ICU/sub-ICU admissions, length of stay, and mortality.
  • Compared outcomes between vaccinated (Vg) and unvaccinated (UVg) groups, and stratified vaccinated patients by serological status.

Main Results:

  • Vg had higher Charlson Comorbidity Index than UVg; no significant differences in mortality, LoS, or ICU/sub-ICU admissions.
  • 86.18% of vaccinated patients had detectable anti-S antibodies (seropositive).
  • Vaccinated seronegative patients had significantly higher in-hospital mortality (33.33%) than seropositive patients (10.69%).
  • Higher mortality in vaccinated seronegative patients aged 45-69; comparable mortality in those ≥70.
  • No outcome differences between Vg and UVg when adjusting for age and comorbidities.

Conclusions:

  • Vaccination did not significantly alter outcomes between vaccinated and unvaccinated groups, considering comorbidities.
  • Vaccinated individuals who were seronegative exhibited a higher mortality rate.
  • Primary prophylaxis and early treatment are crucial, particularly for older and immunosuppressed populations.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...